Impact of Long-Term Erythromycin Therapy on the Oropharyngeal Microbiome and Resistance Gene Reservoir in Non-Cystic Fibrosis Bronchiectasis
ABSTRACT Long-term macrolide therapy reduces rates of pulmonary exacerbation in bronchiectasis. However, little is known about the potential for macrolide therapy to alter the composition and function of the oropharyngeal commensal microbiota or to increase the carriage of transmissible antimicrobia...
Enregistré dans:
Auteurs principaux: | , , , , , , , , , , |
---|---|
Format: | article |
Langue: | EN |
Publié: |
American Society for Microbiology
2018
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/9dccb828593f4ef89e2c94eed49f9713 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|